retatrutide fat loss clinical trials peptide trial Is Weight the Future of Weight Loss Therapy? retatrutide peptide trial Retatrutide—A – What the clinical trials say

STEP-5 extended follow-up to 104 weeks and found that patients who continued semaglutide maintained a 15.2% mean weight reduction, while those who switched to placebo regained roughly two-thirds of lost weight by week 104

Wang J, Zhang Q, Fu H,Han Y, Li X, Zou Q, Yuan S,Sun L

How fast should the dose be escalated

Similar content being viewed by others Diabetes in older adults As both diabetes and aging are major independent risk factors for cardiovascular disease, older patients with these conditions are considered the highest-risk group for cardiovascular disease

This can be useful as a preventative measure and a complementary treatment for conditions typically associated with aging, such as cancer, Alzheimers, chronic obstructive lung disease (COPD), nephropathy, and retinopathy